awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q53746587-012776A0-CE1C-49E8-83F1-B56B8DCDE6B8
Q53746587-012776A0-CE1C-49E8-83F1-B56B8DCDE6B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53746587-012776A0-CE1C-49E8-83F1-B56B8DCDE6B8
Emerging drugs and drug targets against tuberculosis.
P2860
Q53746587-012776A0-CE1C-49E8-83F1-B56B8DCDE6B8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q53746587-012776A0-CE1C-49E8-83F1-B56B8DCDE6B8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ef04bf6fcc4800ff8e3e17e8a8069448edde129b
P2860
Clofazimine and B669 inhibit the proliferative responses and Na+, K(+)-adenosine triphosphatase activity of human lymphocytes by a lysophospholipid-dependent mechanism.